Dr. William Graydon Harker M.D.
Hematologist-Oncologist | Hematology & Oncology
3838 S 700 E Suite 100 Salt Lake City UT, 84106About
Dr. William Harker is a hematologist oncologist practicing in Salt Lake City, UT. Dr. Harker specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Univ of Ut Sch of Med, Salt Lake Cty Ut 1975
University of Utah School of Medicine 1975
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Multicenter Phase II study of estramustine phosphate plus weekly paclitaxel in patients with androgen-independent prostate carcinoma.
- Mitoxantrone resistance in HL-60 leukemia cells: reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II beta isoform.
- Detailed analysis of a randomized phase III trial: can the tolerability of capecitabine plus docetaxel be improved without compromising its survival advantage?
- Hyperphosphatemia, hypocalcemia, and transient renal failure. Results of cytotoxic treatment of acute lymphoblastic leukemia.
- Hyperphosphatemia, hypocalcemia, and transient renal failure. Results of cytotoxic treatment of acute lymphoblastic leukemia.
- Enhancement of colony-stimulating activity production by lithium.
- Enhancement of colony-stimulating activity production by lithium.
- Dissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog.
- Single agent palliative chemotherapy for end-stage Hodgkin's disease.
- Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
- The effect of lithium upon granulocyte production in vitro and in vivo in the mouse.
- Chemotherapy of advanced transitional cell carcinoma of the uroepithelium.
- Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin.
- Mutation at the catalytic site of topoisomerase I in CEM/C2, a human leukemia cell line resistant to camptothecin.
- Peripherally inserted central venous catheters. Low-risk alternatives for ongoing venous access.
Treatments
- Anemia
- Breast Cancer
- Lung Cancer
- Lymphoma
- Extra Corporeal Shockwave Therapy
Professional Memberships
- Member American Assoc. for the Advancement of Science
- Member American Association for Cancer Research
- Member American College of Physicians
- Member American Society of Clinical Oncology
Fellowships
- Stanford University Hospital - Stanford, CA in Oncology 1980
Dr. William Graydon Harker M.D.'s Practice location
Dr. William Graydon Harker M.D.'s reviews
Write ReviewPatient Experience with Dr. Harker
Recommended Articles
- Living with Lymphoma Day by Day
A majority of individuals diagnosed with lymphoma find that they have to make a great deal of adjustments to their lives. There are several physical, emotional, social, and everyday obstacles from diagnosis to remission.Living with lymphoma can be different for every individual, which is why it is...
- Roles of the National Coalition for Cancer Survivorship
The National Coalition for Cancer Survivorship (NCCS) is a nonprofit, cancer advocacy organization that is located just outside of Washington D.C. To date, it is the oldest survivor-led cancer advocacy organization in the United States.The NCCS represents millions of Americans who share a common...
- Black Sabbath's Tony Iommi Discusses Struggles with Lymphoma
Tony Iommi is one of the few rock and roll legends who can say that they fulfilled the industry’s cliché act of getting the band back together. In 2011, the loss of a good friend brought the Black Sabbath guitarist Iommi back into contact with the band’s original lead vocalist, Ozzy Osbourne....
- The Promising Future of Gene Therapy and Lymphoma
Non-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
- Teen with Hodgkin Lymphoma Skates with Her Hero, Mario Lemieux
Lillian Tarasiewicz was diagnosed with stage 3B Hodgkin lymphoma in October of 2015. She currently resides in South Carolina, but because of her father’s Pennsylvania background, she grew up with a love for hockey and for the Pittsburgh Penguins. She always felt a special connection to Mario...
- Microsoft Co-Founder Paul Allen Beats Lymphoma Twice
Beating any type of cancer is a major feat in itself, but billionaire and Microsoft co-founder Paul Allen has defeated lymphoma not once, but twice.Paul's storyNeedless to say, being the co-founder of Microsoft is a pretty big deal. As an American digital pioneer, Paul has been on top of the world....
Nearby Providers
- Dr. William E Nibley M.D.5131 Cottonwood St Salt Lake City UT 84107
- Dr. Nasfat Jameel Shehadeh MD333 S 900 E Salt Lake City UT 84102
- Dr. Scott James Samuelson M.D.333 S 900 E Salt Lake City UT 84102
- Dr. Justin A Call M.D.3590 W 9000 S West Jordan UT 84088
- Dr. Daanish Hoda MD8 Th Ave And C St Salt Lake City UT 84143
- Dr. Brian Lee Mcclune DO1950 CIRCLE OF HOPE DR SALT LAKE CITY UT 84112